503555-23-5 Usage
Uses
Used in Chemical Research:
Tert-Butyl 5-bromo-2-chlorobenzoate is used as a synthetic intermediate for the synthesis of more complex organic compounds. Its role in chemical research is to facilitate the creation of new molecules with potential applications in various fields.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, tert-Butyl 5-bromo-2-chlorobenzoate is used as a building block for the development of new drugs. Its unique structure allows for the creation of molecules with specific therapeutic properties, contributing to the advancement of medicinal chemistry.
Used in Material Science:
Tert-Butyl 5-bromo-2-chlorobenzoate is used as a component in the synthesis of advanced materials, such as polymers and coatings, that may have specialized properties like improved stability, durability, or resistance to environmental factors.
Safety and Handling:
When handling tert-Butyl 5-bromo-2-chlorobenzoate, it is essential to follow standard safety protocols for chemical substances. This includes proper storage, use of personal protective equipment, and adherence to guidelines for chemical disposal and waste management.
Check Digit Verification of cas no
The CAS Registry Mumber 503555-23-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,0,3,5,5 and 5 respectively; the second part has 2 digits, 2 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 503555-23:
(8*5)+(7*0)+(6*3)+(5*5)+(4*5)+(3*5)+(2*2)+(1*3)=125
125 % 10 = 5
So 503555-23-5 is a valid CAS Registry Number.
InChI:InChI=1/C11H12BrClO2/c1-11(2,3)15-10(14)8-6-7(12)4-5-9(8)13/h4-6H,1-3H3
503555-23-5Relevant academic research and scientific papers
RENIN INHIBITORS
-
Page/Page column 30, (2008/06/13)
The present invention relates to novel renin inhibitors of the general Formula (I), and their use as active ingredients in the preparation of pharmaceutical compositions. The invention also concerns related aspects including processes for the preparation of the compounds. These novel renin inhibitors are used in treating cardiovascular events and renal insufficiency.
